FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ian Zagon

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Anatomy

Procedures

Immunohistochemistry

Disorders

Pancreatic Neoplasms

Co-author Network

Publications

TOP 3
Anna M Campbell; Ian S Zagon; Patricia J McLaughlin
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Patricia J McLaughlin; Ian S Zagon
The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease.
Anna M Campbell; Ian S Zagon; Patricia J McLaughlin
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ian Zagon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anna M Campbell; Ian S Zagon; Patricia J McLaughlin
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Brain research bulletin 2013;90():43-51.
2012: Patricia J McLaughlin; Ian S Zagon
The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease.
Biochemical pharmacology 2012;84(6):746-55.
2012: Anna M Campbell; Ian S Zagon; Patricia J McLaughlin
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
Brain research 2012;1472():138-48.
2012: Ian S Zagon; Joseph W Sassani; Anna M Campbell; Patricia J McLaughlin
Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways.
Investigative ophthalmology & visual science 2012;53(6):3234-40.
2012: Patricia J McLaughlin; Michael F Verderame; Cara L Keiper; Ian S Zagon
Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure.
American journal of physiology. Regulatory, integrative and comparative physiology 2012;302(9):R1084-90.
2012: Ian S Zagon; Patricia J McLaughlin
Targeting opioidergic pathways as a novel biological treatment for advanced pancreatic cancer.
Expert review of gastroenterology & hepatology 2012;6(2):133-5.
2012: Patricia J McLaughlin; Jaimon K Stucki; Ian S Zagon
Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck.
Head & neck 2012;34(4):513-9.
2012: Renee N Donahue; Patricia J McLaughlin; Ian S Zagon
Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer.
Experimental biology and medicine (Maywood, N.J.) 2012;237(2):167-77.
2012: James Fanning; Carrie A Hossler; Joshua P Kesterson; Patricia J McLaughlin; Renee N Donahue; Ian S Zagon
Expression of the opioid growth factor-opioid growth factor receptor axis in human ovarian cancer.
Gynecologic oncology 2012;124(2):319-24.
2011: Patricia J McLaughlin; Christian A Pothering; Jessica A Immonen; Ian S Zagon
Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats.
Experimental biology and medicine (Maywood, N.J.) 2011;236(10):1122-32.
2011: Ian S Zagon; Patricia J McLaughlin
Targeting opioid signaling in Crohn's disease: new therapeutic pathways.
Expert review of gastroenterology & hepatology 2011;5(5):555-8.
2011: Renee N Donahue; Patricia J McLaughlin; Ian S Zagon
Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.
Experimental biology and medicine (Maywood, N.J.) 2011;236(9):1036-50.
2011: Renee N Donahue; Patricia J McLaughlin; Ian S Zagon
The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice.
Gynecologic oncology 2011;122(2):382-8.
2011: Renee N Donahue; Patricia J McLaughlin; Ian S Zagon
Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin.
Experimental biology and medicine (Maywood, N.J.) 2011;236(7):883-95.
2011: Jill P Smith; Sandra I Bingaman; David T Mauger; Christopher O McGovern; Aparna Mukherjee; Francesca Ruggiero; Ian S Zagon
Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial.
Digestive diseases and sciences 2011;56(7):2088-97.
2011: Ian S Zagon; Renee N Donahue; Robert H Bonneau; Patricia J McLaughlin
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Immunobiology 2011;216(5):579-90.
2011: Kristen A Rahn; Patricia J McLaughlin; Ian S Zagon
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
Brain research 2011;1381():243-53.
2011: Ian S Zagon; Renee N Donahue; Robert H Bonneau; Patricia J McLaughlin
B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
Immunobiology 2011;216(1-2):173-83.
2010: Patricia J McLaughlin; Moshe Rogosnitzky; Ian S Zagon
Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors.
Experimental biology and medicine (Maywood, N.J.) 2010;235(11):1292-9.
2010: Matthew S Klocek; Joseph Sassani; Renee N Donahue; Patricia J McLaughlin; Ian S Zagon
Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis.
Investigative ophthalmology & visual science 2010;51(10):5054-61.
2010: Fan Cheng; Patricia J McLaughlin; Ian S Zagon
Regulation of cell proliferation by the opioid growth factor receptor is dependent on karyopherin beta and Ran for nucleocytoplasmic trafficking.
Experimental biology and medicine (Maywood, N.J.) 2010;235(9):1093-101.
2010: Fan Cheng; Patricia J McLaughlin; William A Banks; Ian S Zagon
Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation.
American journal of physiology. Regulatory, integrative and comparative physiology 2010;299(3):R774-85.
2010: Ian S Zagon; Joseph Sassani; Melissa A Carroll; Patricia J McLaughlin
Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.
Brain research bulletin 2010;81(2-3):248-55.
2010: Patricia J McLaughlin; Joseph Sassani; Matthew S Klocek; Ian S Zagon
Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.
Brain research bulletin 2010;81(2-3):236-47.
2010: Diego M Avella; Eric T Kimchi; Renee N Donahue; Hephzibah Rani S Tagaram; Patricia J McLaughlin; Ian S Zagon; Kevin F Staveley-O'Carroll
The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer.
American journal of physiology. Regulatory, integrative and comparative physiology 2010;298(2):R459-66.
2010: Ian S Zagon; Kristen A Rahn; Robert H Bonneau; Anthony P Turel; Patricia J McLaughlin
Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
Brain research 2010;1310():154-61.
2009: Ian S Zagon; Matthew S Klocek; Joseph Sassani; Patricia J McLaughlin
Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus.
Archives of ophthalmology 2009;127(11):1468-73.
2009: Ian S Zagon; Kristen A Rahn; Anthony P Turel; Patricia J McLaughlin
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Experimental biology and medicine (Maywood, N.J.) 2009;234(11):1383-92.
2009: Matthew S Klocek; Joseph Sassani; Patricia J McLaughlin; Ian S Zagon
Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.
Experimental eye research 2009;89(5):686-92.
2009: Ian S Zagon; Renee N Donahue; Patricia J McLaughlin
Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.
American journal of physiology. Regulatory, integrative and comparative physiology 2009;297(4):R1154-61.
2009: Fan Cheng; Patricia J McLaughlin; William A Banks; Ian S Zagon
Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation.
American journal of physiology. Regulatory, integrative and comparative physiology 2009;297(3):R844-52.
2009: Renee N Donahue; Patricia J McLaughlin; Ian S Zagon
Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis.
American journal of physiology. Regulatory, integrative and comparative physiology 2009;296(6):R1716-25.
2009: Fan Cheng; Patricia J McLaughlin; Michael F Verderame; Ian S Zagon
Dependence on nuclear localization signals of the opioid growth factor receptor in the regulation of cell proliferation.
Experimental biology and medicine (Maywood, N.J.) 2009;234(5):532-41.
2009: Patricia J McLaughlin; Ian S Zagon; Sunny S Park; Andrea Conway; Renee N Donahue; David Goldenberg
Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
BMC cancer 2009;9():369.
2009: Fan Cheng; Patricia J McLaughlin; Michael F Verderame; Ian S Zagon
The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.
Molecular biology of the cell 2009;20(1):319-27.
2008: David Goldenberg; Ian S Zagon; Fred Fedok; Henry S Crist; Patricia J McLaughlin
Expression of opioid growth factor (OGF)-OGF receptor (OGFr) axis in human nonmedullary thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2008;18(11):1165-70.
2008: Patricia J McLaughlin; Shawn Kreiner; Clinton R Morgan; Ian S Zagon
Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor.
International journal of oncology 2008;33(4):751-7.
2008: Ian S Zagon; Shawn Kreiner; Jeffery J Heslop; Andrea B Conway; Clinton R Morgan; Patricia J McLaughlin
Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor.
International journal of oncology 2008;33(2):317-23.
2008: Ian S Zagon; Renee N Donahue; Moshe Rogosnitzky; Patricia J McLaughlin
Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function.
Experimental biology and medicine (Maywood, N.J.) 2008;233(8):968-79.
2008: Ian S Zagon; Matthew S Klocek; James W Griffith; Joseph Sassani; András M Komáromy; Patricia J McLaughlin
Prevention of exuberant granulation tissue and neovascularization in the rat cornea by naltrexone.
Archives of ophthalmology 2008;126(4):501-6.
2008: Fan Cheng; Patricia J McLaughlin; Michael F Verderame; Ian S Zagon
The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer.
Molecular cancer 2008;7():5.
2007: Ian S Zagon; Kristen A Rahn; Patricia J McLaughlin
Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells.
Neuropeptides 2007;41(6):441-52.
2007: Fan Cheng; Ian S Zagon; Michael F Verderame; Patricia J McLaughlin
The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer.
Cancer research 2007;67(21):10511-8.
2007: Ian S Zagon; Matthew S Klocek; Joseph Sassani; Patricia J McLaughlin
Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus.
Archives of ophthalmology 2007;125(8):1082-8.
2007: Ian S Zagon; Joseph Sassani; Roland L Myers; Patricia J McLaughlin
Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium.
Brain research bulletin 2007;72(1):18-24.
2007: Matthew S Klocek; Joseph Sassani; Patricia J McLaughlin; Ian S Zagon
Topically applied naltrexone restores corneal reepithelialization in diabetic rats.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2007;23(2):89-102.
2007: Ian S Zagon; Michael F Verderame; Jody Hankins; Patricia J McLaughlin
Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.
International journal of oncology 2007;30(4):775-83.
2007: Jill P Smith; Heather Stock; Sandra I Bingaman; David T Mauger; Moshe Rogosnitzky; Ian S Zagon
Low-dose naltrexone therapy improves active Crohn's disease.
The American journal of gastroenterology 2007;102(4):820-8.
2007: Patricia J McLaughlin; Michael F Verderame; Jody L Hankins; Ian S Zagon
Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.
International journal of molecular medicine 2007;19(3):421-8.
2006: Ian S Zagon; Joseph Sassani; Kristin J Malefyt; Patricia J McLaughlin
Regulation of corneal repair by particle-mediated gene transfer of opioid growth factor receptor complementary DNA.
Archives of ophthalmology 2006;124(11):1620-4.
2006: Ian S Zagon; Matthew S Klocek; Joseph Sassani; David T Mauger; Patricia J McLaughlin
Corneal safety of topically applied naltrexone.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2006;22(5):377-87.
2006: Ian S Zagon; Joseph Sassani; Patricia J McLaughlin
Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone.
Cornea 2006;25(7):821-9.
2006: Ian S Zagon; Patricia J McLaughlin
Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers.
International journal of oncology 2006;29(2):489-94.
2006: Patricia J McLaughlin; Ian S Zagon
Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor.
International journal of oncology 2006;28(6):1577-83.
2006: Ian S Zagon; Joseph Sassani; Patricia J McLaughlin
Insulin treatment ameliorates impaired corneal reepithelialization in diabetic rats.
Diabetes 2006;55(4):1141-7.
2005: Ian S Zagon; Jeffrey R Jaglowski; Michael F Verderame; Jill P Smith; Alphonse E Leure-duPree; Patricia J McLaughlin
Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma.
Cancer chemotherapy and pharmacology 2005;56(5):510-20.
2005: Ian S Zagon; Patricia J McLaughlin
Opioids and differentiation in human cancer cells.
Neuropeptides 2005;39(5):495-505.
2005: Ian S Zagon; Joseph Sassani; Michael F Verderame; Patricia J McLaughlin
Particle-mediated gene transfer of opioid growth factor receptor cDNA regulates cell proliferation of the corneal epithelium.
Cornea 2005;24(5):614-9.
2005: Jeffrey R Jaglowski; Ian S Zagon; Brendan C Stack; Michael F Verderame; Alphonse E Leure-duPree; Jeffrey D Manning; Patricia J McLaughlin
Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.
Cancer chemotherapy and pharmacology 2005;56(1):97-104.
2005: Patricia J McLaughlin; Jeffrey R Jaglowski; Michael F Verderame; Brendan C Stack; Alphonse E Leure-duPree; Ian S Zagon
Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor.
International journal of oncology 2005;26(3):809-16.
2005: Ian S Zagon; Torre B Ruth; Patricia J McLaughlin
Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium.
The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology 2005;282(1):24-37.
2004: Jill P Smith; Wayne B Stanley; Michael F Verderame; Ian S Zagon
The functional significance of the cholecystokinin-C (CCK-C) receptor in human pancreatic cancer.
Pancreas 2004;29(4):271-7.
2004: Ian S Zagon; Patricia J McLaughlin
Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
International journal of oncology 2004;24(6):1443-8.
2004: Jill P Smith; Michael F Verderame; Elizabeth N Ballard; Ian S Zagon
Functional significance of gastrin gene expression in human cancer cells.
Regulatory peptides 2004;117(3):167-73.
2004: Ian S Zagon; Patricia J McLaughlin
Gene expression of OGFr in the developing and adult rat brain and cerebellum.
Brain research bulletin 2004;63(1):57-63.
2004: Jill P Smith; Robert L Conter; Sandra I Bingaman; Harold A Harvey; David T Mauger; Mejdi Ahmad; Laurence M Demers; Wayne B Stanley; Patricia J McLaughlin; Ian S Zagon
Treatment of advanced pancreatic cancer with opioid growth factor: phase I.
Anti-cancer drugs 2004;15(3):203-9.
2004: Patricia J McLaughlin; Brendan C Stack; Kristi M Braine; James D Ruda; Ian S Zagon
Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration.
International journal of oncology 2004;24(1):227-32.
2003: Ian S Zagon; Michael F Verderame; Patricia J McLaughlin
The expression and function of the OGF-OGFr axis - a tonically active negative regulator of growth - in COS cells.
Neuropeptides 2003;37(5):290-7.
2003: Patricia J McLaughlin; Roger J Levin; Ian S Zagon
Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice.
Cancer letters 2003;199(2):209-17.
2003: Joseph Sassani; Ian S Zagon; Patricia J McLaughlin
Opioid growth factor modulation of corneal epithelium: uppers and downers.
Current eye research 2003;26(5):249-62.
2003: Ian S Zagon; Patricia J McLaughlin
Opioids and the apoptotic pathway in human cancer cells.
Neuropeptides 2003;37(2):79-88.
2003: Patricia J McLaughlin; Brendan C Stack; Roger J Levin; Fred G Fedok; Ian S Zagon
Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck.
Cancer 2003;97(7):1701-10.
2003: Ian S Zagon; Torre B Ruth; Alphonse E Leure-duPree; Joseph Sassani; Patricia J McLaughlin
Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea.
Brain research 2003;967(1-2):37-47.
2003: Ian S Zagon; Frank M Essis; Michael F Verderame; Dean A Healy; Robert G Atnip; Patricia J McLaughlin
Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery.
Journal of vascular surgery 2003;37(3):636-43.
2002: Jill P Smith; Michael F Verderame; Patricia McLaughlin; Melissa Martenis; Elizabeth Ballard; Ian S Zagon
Characterization of the CCK-C (cancer) receptor in human pancreatic cancer.
International journal of molecular medicine 2002;10(6):689-94.
2002: Ian S Zagon; Joe B Jenkins; Joseph Sassani; James D Wylie; Torre B Ruth; Jamie L Fry; C Max Lang; Patricia J McLaughlin
Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat.
Diabetes 2002;51(10):3055-62.
2002: John Blebea; Jonathan-Hien Vu; Shahin Assadnia; Patricia J McLaughlin; Robert G Atnip; Ian S Zagon
Differential effects of vascular growth factors on arterial and venous angiogenesis.
Journal of vascular surgery 2002;35(3):532-8.
2002: Ian S Zagon; Michael F Verderame; Patricia J McLaughlin
The biology of the opioid growth factor receptor (OGFr).
Brain research. Brain research reviews 2002;38(3):351-76.
2002: Patricia J McLaughlin; James D Wylie; Glenn Bloom; James W Griffith; Ian S Zagon
Chronic exposure to the opioid growth factor, [Met5]-enkephalin, during pregnancy: maternal and preweaning effects.
Pharmacology, biochemistry, and behavior 2002;71(1-2):171-81.
2001: Ian S Zagon; J D Wylie; WJ Hurst; Patricia J McLaughlin
Transplacental transfer of the opioid growth factor, [Met(5)]-enkephalin, in rats.
Brain research bulletin 2001;55(3):341-6.
2001: Ian S Zagon; Joseph Sassani; Torre B Ruth; Patricia J McLaughlin
Epithelial adhesion complexes and organ culture of the human cornea.
Brain research 2001;900(2):205-13.
2000: Ian S Zagon; M F Verderame; Warren Zimmer; Patricia J McLaughlin
Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse.
Brain research. Molecular brain research 2000;84(1-2):106-14.
2000: Ian S Zagon; Joseph Sassani; Torre B Ruth; Patricia J McLaughlin
Cellular dynamics of corneal wound re-epithelialization in the rat. III. Mitotic activity.
Brain research 2000;882(1-2):169-79.
2000: Ian S Zagon; C D Roesener; Michael F Verderame; B M Ohlsson-Wilhelm; Roger J Levin; Patricia J McLaughlin
Opioid growth factor regulates the cell cycle of human neoplasias.
International journal of oncology 2000;17(5):1053-61.
2000: Jill P Smith; Robert L Conter; T M Demers; Patricia J McLaughlin; Ian S Zagon
Elevated levels of opioid growth factor in the plasma of patients with pancreatic cancer.
Pancreas 2000;21(2):158-64.
2000: John Blebea; J E Mazo; T K Kihara; J H Vu; Patricia J McLaughlin; Robert G Atnip; Ian S Zagon
Opioid growth factor modulates angiogenesis.
Journal of vascular surgery 2000;32(2):364-73.
2000: R P Wilson; Patricia J McLaughlin; C Max Lang; Ian S Zagon
The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin.
Cell proliferation 2000;33(2):63-73.
2000: Ian S Zagon; Michael F Verderame; S S Allen; Patricia J McLaughlin
Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans.
Brain research 2000;856(1-2):75-83.
2000: Patricia J McLaughlin; Roger J Levin; Ian S Zagon
The opioid growth factor receptor in human head and neck squamous cell carcinoma.
International journal of molecular medicine 2000;5(2):191-6.
2000: R Zalys; Ian S Zagon; R H Bonneau; C Max Lang; Patricia J McLaughlin
In vivo effects of chronic treatment with [MET5]-enkephalin on hematological values and natural killer cell activity in athymic mice.
Life sciences 2000;66(9):829-34.
2000: Ian S Zagon; Joseph Sassani; Patricia J McLaughlin
Reepithelialization of the human cornea is regulated by endogenous opioids.
Investigative ophthalmology & visual science 2000;41(1):73-81.
2000: Ian S Zagon; Jill P Smith; Robert L Conter; Patricia J McLaughlin
Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.
International journal of molecular medicine 2000;5(1):77-84.
1999: Ian S Zagon; Michael F Verderame; S S Allen; P J McLaughlin
Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met(5)]enkephalin.
Brain research 1999;849(1-2):147-54.
1999: GJ Bisignani; Patricia J McLaughlin; SD Ordille; M S Beltz; M V Jarowenko; Ian S Zagon
Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor.
The Journal of urology 1999;162(6):2186-91.
1999: Ian S Zagon; Y Wu; Patricia J McLaughlin
Opioid growth factor and organ development in rat and human embryos.
Brain research 1999;839(2):313-22.
1999: Ian S Zagon; Joseph Sassani; Patricia J McLaughlin
Cellular dynamics of corneal wound re-epithelialization in the rat. II. DNA synthesis of the ocular surface epithelium following wounding.
Brain research 1999;839(2):243-52.
1999: WJ Hurst; Ian S Zagon; H Y Aboul-Enein
A rapid sample preparation method for the HPLC determination of the opioid antagonist naltrexone in serum.
Die Pharmazie 1999;54(8):595-6.
1999: Patricia J McLaughlin; Roger J Levin; Ian S Zagon
Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor.
International journal of oncology 1999;14(5):991-8.
1999: Ian S Zagon; Joseph Sassani; Patricia J McLaughlin
Cellular dynamics of corneal wound re-epithelialization in the rat. I. Fate of ocular surface epithelial cells synthesizing DNA prior to wounding.
Brain research 1999;822(1-2):149-63.
1999: Ian S Zagon; Jill P Smith; Patricia J McLaughlin
Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor.
International journal of oncology 1999;14(3):577-84.
1999: Patricia J McLaughlin; Ian S Zagon; J Skitzki
Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor.
International journal of oncology 1999;14(2):373-80.
1999: Jill P Smith; Michael F Verderame; Ian S Zagon
Antisense oligonucleotides to gastrin inhibit growth of human pancreatic cancer.
Cancer letters 1999;135(1):107-12.
1998: R P Wilson; Patricia J McLaughlin; C Max Lang; Ian S Zagon
Temporal variation in cellular proliferation during recornification of mouse tail skin.
Cell proliferation 1998;31(5-6):191-201.
1998: Ian S Zagon; Joseph Sassani; Patricia J McLaughlin
Re-epithelialization of the rabbit cornea is regulated by opioid growth factor.
Brain research 1998;803(1-2):61-8.
1998: Ian S Zagon; Joseph Sassani; Patricia J McLaughlin
Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors.
Brain research 1998;798(1-2):254-60.
1998: Ian S Zagon; Joseph Sassani; Y Wu; Patricia J McLaughlin
The autocrine derivation of the opioid growth factor, [Met5]-enkephalin, in ocular surface epithelium.
Brain research 1998;792(1):72-8.
1998: Y Wu; Patricia J McLaughlin; Ian S Zagon
Ontogeny of the opioid growth factor, [Met5]-enkephalin, preproenkephalin gene expression, and the zeta opioid receptor in the developing and adult aorta of rat.
Developmental dynamics : an official publication of the American Association of Anatomists 1998;211(4):327-37.
1998: Jill P Smith; A H Shih; M G Wotring; Patricia J McLaughlin; Ian S Zagon
Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma.
International journal of oncology 1998;12(2):411-9.
1998: Ian S Zagon; WJ Hurst; Patricia J McLaughlin
Naltrexone is not detected in preweaning rats following transplacental exposure: implications for growth modulation.
Life sciences 1998;62(3):221-8.
1998: Ian S Zagon; SW Tobias; SD Hytrek; Patricia J McLaughlin
Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters mu opioid receptors.
Pharmacology, biochemistry, and behavior 1998;59(1):201-7.
1997: Patricia J McLaughlin; SW Tobias; C Max Lang; Ian S Zagon
Opioid receptor blockade during prenatal life modifies postnatal behavioral development.
Pharmacology, biochemistry, and behavior 1997;58(4):1075-82.
1997: Patricia J McLaughlin; SW Tobias; C Max Lang; Ian S Zagon
Chronic exposure to the opioid antagonist naltrexone during pregnancy: maternal and offspring effects.
Physiology & behavior 1997;62(3):501-8.
1997: Ian S Zagon; Joseph Sassani; E R Kane; Patricia J McLaughlin
Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor.
Brain research 1997;759(1):92-102.
1997: Ian S Zagon; Y Wu; Patricia J McLaughlin
Opioid growth factor is present in human and mouse gastrointestinal tract and inhibits DNA synthesis.
The American journal of physiology 1997;272(4 Pt 2):R1094-104.
1997: Roger J Levin; Y Wu; Patricia J McLaughlin; Ian S Zagon
Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma.
The Laryngoscope 1997;107(3):335-9.
1997: Ian S Zagon; SD Hytrek; Jill P Smith; Patricia J McLaughlin
Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice.
Cancer letters 1997;112(2):167-75.
1997: Ian S Zagon; SW Tobias; Patricia J McLaughlin
Endogenous opioids and prenatal determinants of neuroplasticity.
Advances in experimental medicine and biology 1997;429():289-303.
1997: Ian S Zagon; WJ Hurst; Patricia J McLaughlin
Transplacental transfer of naltrexone in rats.
Life sciences 1997;61(13):1261-7.
1997: Ian S Zagon; WJ Hurst; Patricia J McLaughlin
Identification of [Met5]-enkephalin in developing, adult, and renewing tissues by reversed-phase high performance liquid chromatography and radioimmunoassay.
Life sciences 1997;61(4):363-70.
1996: Jill P Smith; E A Stock; M G Wotring; Patricia J McLaughlin; Ian S Zagon
Characterization of the CCK-B/gastrin-like receptor in human colon cancer.
The American journal of physiology 1996;271(3 Pt 2):R797-805.
1996: Ian S Zagon; S D Hytrek; C Max Lang; Jill P Smith; T J McGarrity; Y Wu; Patricia J McLaughlin
Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer.
The American journal of physiology 1996;271(3 Pt 2):R780-6.
1996: Ian S Zagon; S D Hytrek; Patricia J McLaughlin
Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture.
The American journal of physiology 1996;271(3 Pt 2):R511-8.
1996: T Isayama; Patricia J McLaughlin; Ian S Zagon
Ontogeny of preproenkephalin mRNA expression in the rat retina.
Visual neuroscience 1996;13(4):695-704.
1996: S D Hytrek; Jill P Smith; T J McGarrity; Patricia J McLaughlin; C Max Lang; Ian S Zagon
Identification and characterization of zeta-opioid receptor in human colon cancer.
The American journal of physiology 1996;271(1 Pt 2):R115-21.
1996: Jill P Smith; A Shih; Y Wu; Patricia J McLaughlin; Ian S Zagon
Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion.
The American journal of physiology 1996;270(5 Pt 2):R1078-84.
1996: S D Hytrek; Patricia J McLaughlin; C Max Lang; Ian S Zagon
Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone.
Cancer letters 1996;101(2):159-64.
1996: Ian S Zagon; Y Wu; Patricia J McLaughlin
Opioid growth factor-dependent DNA synthesis in the neonatal rat aorta.
The American journal of physiology 1996;270(1 Pt 2):R22-32.
1995: Ian S Zagon; Patricia J McLaughlin
Gene-peptide relationships in the developing rat brain: the response of preproenkephalin mRNA and [Met5]-enkephalin to acute opioid antagonist (naltrexone) exposure.
Brain research. Molecular brain research 1995;33(1):111-20.
1995: T Isayama; W J Hurst; Patricia J McLaughlin; Ian S Zagon
Ontogeny of the opioid growth factor, [Met5]-enkephalin, and its binding activity in the rat retina.
Visual neuroscience 1995;12(5):939-50.
1995: Ian S Zagon; Joseph Sassani; Patricia J McLaughlin
Opioid growth factor modulates corneal epithelial outgrowth in tissue culture.
The American journal of physiology 1995;268(4 Pt 2):R942-50.
1995: Ian S Zagon; Joseph Sassani; G Allison; Patricia J McLaughlin
Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta (zeta) opioid receptor in vertebrate cornea.
Brain research 1995;671(1):105-11.
1995: Jill P Smith; A P Fantaskey; G Liu; Ian S Zagon
Identification of gastrin as a growth peptide in human pancreatic cancer.
The American journal of physiology 1995;268(1 Pt 2):R135-41.
1995: Steven R Goodman; Warren Zimmer; M B Clark; Ian S Zagon; Jane E Barker; MIchael Bloom
Brain spectrin: of mice and men.
Brain research bulletin 1995;36(6):593-606.
1994: M B Clark; Y Ma; MIchael Bloom; Jane E Barker; Ian S Zagon; Warren Zimmer; Steven R Goodman
Brain alpha erythroid spectrin: identification, compartmentalization, and beta spectrin associations.
Brain research 1994;663(2):223-36.
1994: Ian S Zagon; Y Wu; Patricia J McLaughlin
Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner.
The American journal of physiology 1994;267(3 Pt 2):R645-52.
1994: Ian S Zagon; Y Wu; Patricia J McLaughlin
Opioid antagonist modulation of DNA synthesis in mouse tongue epithelium is circadian dependent.
Pharmacology, biochemistry, and behavior 1994;48(3):709-14.
1994: Jill P Smith; G Liu; V Soundararajan; Patricia J McLaughlin; Ian S Zagon
Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines.
The American journal of physiology 1994;266(1 Pt 2):R277-83.
1994: Ian S Zagon; T Isayama; Patricia J McLaughlin
Preproenkephalin mRNA expression in the developing and adult rat brain.
Brain research. Molecular brain research 1994;21(1-2):85-98.
1993: Ian S Zagon; Patricia J McLaughlin
Production and characterization of polyclonal and monoclonal antibodies to the zeta (zeta) opioid receptor.
Brain research 1993;630(1-2):295-302.
1993: T Isayama; Steven R Goodman; Ian S Zagon
Localization of spectrin isoforms in the adult mouse heart.
Cell and tissue research 1993;274(1):127-33.
1993: Jill P Smith; C A Rickabaugh; Patricia J McLaughlin; Ian S Zagon
Cholecystokinin receptors and PANC-1 human pancreatic cancer cells.
The American journal of physiology 1993;265(1 Pt 1):G149-55.
1993: Ian S Zagon; Steven R Goodman; Patricia J McLaughlin
Zeta (zeta), the opioid growth factor receptor: identification and characterization of binding subunits.
Brain research 1993;605(1):50-6.
1993: R P Wilson; Ian S Zagon; D R Larach; C Max Lang
Cardiovascular and respiratory effects of tiletamine-zolazepam.
Pharmacology, biochemistry, and behavior 1993;44(1):1-8.
1992: R P Wilson; Ian S Zagon; D R Larach; C Max Lang
Antinociceptive properties of tiletamine-zolazepam improved by addition of xylazine or butorphanol.
Pharmacology, biochemistry, and behavior 1992;43(4):1129-33.
1992: Ian S Zagon; Denise M Gibo; Patricia J McLaughlin
Ontogeny of zeta (zeta), the opioid growth factor receptor, in the rat brain.
Brain research 1992;596(1-2):149-56.
1992: Warren Zimmer; Y Ma; Ian S Zagon; Steven R Goodman
Developmental expression of brain beta-spectrin isoform messenger RNAs.
Brain research 1992;594(1):75-83.
1992: Warren Zimmer; Ian S Zagon; L A Casoria; Steven R Goodman
Identification of an amelin isoform located in axons.
Brain research 1992;582(1):94-100.
1992: Ian S Zagon; Patricia J McLaughlin
An opioid growth factor regulates the replication of microorganisms.
Life sciences 1992;50(16):1179-87.
1991: T Isayama; Ian S Zagon
Localization of preproenkephalin A mRNA in the neonatal rat retina.
Brain research bulletin 1991;27(6):805-8.
1991: T Isayama; Steven R Goodman; Ian S Zagon
Spectrin isoforms in the mammalian retina.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1991;11(11):3531-8.
1991: A F Sikorski; G Terlecki; Ian S Zagon; Steven R Goodman
Synapsin I-mediated interaction of brain spectrin with synaptic vesicles.
The Journal of cell biology 1991;114(2):313-8.
1991: Ian S Zagon; Denise M Gibo; Patricia J McLaughlin
Zeta (zeta), a growth-related opioid receptor in developing rat cerebellum: identification and characterization.
Brain research 1991;551(1-2):28-35.
1991: T Isayama; Patricia J McLaughlin; Ian S Zagon
Endogenous opioids regulate cell proliferation in the retina of developing rat.
Brain research 1991;544(1):79-85.
1991: Ian S Zagon; Patricia J McLaughlin
Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system.
Brain research 1991;542(2):318-23.
1990: Ian S Zagon; Denise M Gibo; Patricia J McLaughlin
Adult and developing human cerebella exhibit different profiles of opioid binding sites.
Brain research 1990;523(1):62-8.
1990: Ian S Zagon; Steven R Goodman; Patricia J McLaughlin
Demonstration and characterization of zeta (zeta), a growth-related opioid receptor, in a neuroblastoma cell line.
Brain research 1990;511(2):181-6.
1990: Ian S Zagon; Denise M Gibo; Patricia J McLaughlin
Expression of zeta (zeta), a growth-related opioid receptor, in metastatic adenocarcinoma of the human cerebellum.
Journal of the National Cancer Institute 1990;82(4):325-7.
1990: Ian S Zagon; Patricia J McLaughlin
Ultrastructural localization of enkephalin-like immunoreactivity in developing rat cerebellum.
Neuroscience 1990;34(2):479-89.
1990: Ian S Zagon; Patricia J McLaughlin
Opioid antagonist (naltrexone) stimulation of cell proliferation in human and animal neuroblastoma and human fibrosarcoma cells in culture.
Neuroscience 1990;37(1):223-6.
1989: Steven R Goodman; L L Lopresti; B M Riederer; A Sikorski; Ian S Zagon
Brain spectrin(240/235A): a novel astrocyte specific spectrin isoform.
Brain research bulletin 1989;23(4-5):311-6.
1989: Ian S Zagon; S R Goodman
Absence of brain spectrin(240/235) in dendrites of mammalian brain.
Brain research bulletin 1989;23(1-2):19-24.
1989: Ian S Zagon; Patricia J McLaughlin
Endogenous opioid systems regulate growth of neural tumor cells in culture.
Brain research 1989;490(1):14-25.
1989: Ian S Zagon
Endogenous opioids and neural cancer: an immunoelectron microscopic study.
Brain research bulletin 1989;22(6):1023-9.
1989: Ian S Zagon; Patricia J McLaughlin
Naloxone modulates body and organ growth of rats: dependency on the duration of opioid receptor blockade and stereospecificity.
Pharmacology, biochemistry, and behavior 1989;33(2):325-8.
1989: Ian S Zagon; Steven R Goodman; Patricia J McLaughlin
Characterization of zeta (zeta): a new opioid receptor involved in growth.
Brain research 1989;482(2):297-305.
1989: K F Hauser; Patricia J McLaughlin; Ian S Zagon
Endogenous opioid systems and the regulation of dendritic growth and spine formation.
The Journal of comparative neurology 1989;281(1):13-22.
1989: Ian S Zagon; Patricia J McLaughlin
Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors.
Brain research 1989;480(1-2):16-28.
1989: Ian S Zagon; E Zagon; Patricia J McLaughlin
Opioids and the developing organism: a comprehensive bibliography, 1984-1988.
Neuroscience and biobehavioral reviews 1989;13(4):207-35.
1988: Ian S Zagon
Endogenous opioid systems and neural cancer: transmission and scanning electron microscopic studies of murine neuroblastoma in tissue culture.
Brain research bulletin 1988;21(5):777-84.
1988: B M Riederer; L L Lopresti; K E Krebs; Ian S Zagon; Steven R Goodman
Brain spectrin(240/235) and brain spectrin(240/235E): conservation of structure and location within mammalian neural tissue.
Brain research bulletin 1988;21(4):607-16.
1988: Ian S Zagon; Steven R Goodman; Patricia J McLaughlin
Characterization of opioid binding sites in murine neuroblastoma.
Brain research 1988;449(1-2):80-8.
1988: G D Hess; Ian S Zagon
Endogenous opioid systems and neural development: ultrastructural studies in the cerebellar cortex of infant and weanling rats.
Brain research bulletin 1988;20(4):473-8.
1988: Steven R Goodman; K E Krebs; C F Whitfield; B M Riederer; Ian S Zagon
Spectrin and related molecules.
CRC critical reviews in biochemistry 1988;23(2):171-234.
1988: Ian S Zagon; P McLaughlin
Endogenous opioids and the growth regulation of a neural tumor.
Life sciences 1988;43(16):1313-8.
1987: K E Krebs; Ian S Zagon; Steven R Goodman
Amelin: a 4.1-related spectrin-binding protein found in neuronal cell bodies and dendrites.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1987;7(12):3907-14.
1987: Ian S Zagon; Patricia J McLaughlin; Steven R Goodman; R E Rhodes
Opioid receptors and endogenous opioids in diverse human and animal cancers.
Journal of the National Cancer Institute 1987;79(5):1059-65.
1987: K E Krebs; S M Prouty; Ian S Zagon; Steven R Goodman
Structural and functional relationship of red blood cell protein 4.1 to synapsin I.
The American journal of physiology 1987;253(4 Pt 1):C500-5.
1987: K E Krebs; Ian S Zagon; Steven R Goodman
Amelin and synapsin I are 4.1 related spectrin binding proteins in brain.
Brain research bulletin 1987;18(6):793-8.
1987: K E Krebs; Ian S Zagon; R Sihag; Steven R Goodman
Brain protein 4.1 subtypes: a working hypothesis.
BioEssays : news and reviews in molecular, cellular and developmental biology 1987;6(6):274-9.
1987: Ian S Zagon
Endogenous opioids, opioid receptors, and neuronal development.
NIDA research monograph 1987;78():61-71.
1986: K E Krebs; Ian S Zagon; Steven R Goodman
A rapid purification of synapsin I: a neuron specific spectrin binding protein.
Brain research bulletin 1986;17(2):237-41.
1986: Steven R Goodman; Ian S Zagon; D B Coleman; P J McLaughlin
Spectrin expression in neuroblastoma cells.
Brain research bulletin 1986;16(5):597-602.
1984: L A Casoria; Ian S Zagon; S E Bernstein; S B Shohet; P J McLaughlin; Steven R Goodman
Normal content of brain spectrin-like protein in sph/sph mice.
British journal of haematology 1984;58(2):277-88.
1984: Steven R Goodman; Ian S Zagon; C F Whitfield; L A Casoria; S B Shohet; S E Bernstein; P J McLaughlin; T L Laskiewicz
A spectrin-like protein from mouse brain membranes: phosphorylation of the 235,000-dalton subunit.
The American journal of physiology 1984;247(1 Pt 1):C61-73.
1984: Steven R Goodman; L A Casoria; D B Coleman; Ian S Zagon
Identification and location of brain protein 4.1.
Science (New York, N.Y.) 1984;224(4656):1433-6.
1983: Steven R Goodman; Ian S Zagon; C F Whitfield; L A Casoria; P J McLaughlin; T L Laskiewicz
A spectrin-like protein from mouse brain membranes: immunological and structural correlations with erythrocyte spectrin.
Cell motility 1983;3(5-6):635-47.